The Mount Sinai COVID-19 Biobank is a joint effort between the Mount Sinai Clinical Intelligence Center (MSCIC) and Human Immune Monitoring Center (HIMC) that arose organically during the COVID-19 pandemic to rapidly collect blood samples from hundreds of COVID-19 patients admitted to Mount Sinai hospitals and serve as the backbone for COVID-19 research. During the peak of the first surge, a volunteer team of more than 100 research staff, nurses, doctors, and scientists collected biological specimens from nearly 800 individuals and collection has continued into 2021. The core team behind the biobank has generated a diverse set of molecular data using state-of-the-art technologies in immunology and genomics and used that data to gain valuable insight into COVID-19. Now, in collaboration with the Office of Research Services, MSCIC and HIMC are releasing the COVID-19 biobank data through the Data Ark to approved applicants in an effort to further expand COVID-19 research within Mount Sinai.

To obtain access to this data, please submit a research proposal here and clicking on “COVID-19 Biobank Study Submission Form”. Requests will be fielded by the Mount Sinai COVID-19 Biobank Study Review Committee, which will serve to streamline work efforts, maintain a high quality of research, and promote a culture of resource sharing, in the order in which it is received. Once approved, you will receive an email with your approval status and instructions on how to gain access to the requested datasets.

If you have questions about the approval process or how to access data, please contact Steven Ascolillo at

If you are interested in more information or would like to collaborate with the Mount Sinai Clinical Intelligence Center, please reach out to

To find out more about the Human Immune Monitoring Center, please click here.

To use this data, you must read, agree and sign the Data Use Agreement here (you must be logged in through the Mount Sinai campus network or secure remote VPN).